期刊
BRITISH JOURNAL OF HAEMATOLOGY
卷 116, 期 1, 页码 155-157出版社
BLACKWELL PUBLISHING LTD
DOI: 10.1046/j.1365-2141.2002.03241.x
关键词
beta-thalassaemia; chronic myeloid leukaemia; anagrelide; hydroxyurea; haemoglobin F
类别
The co-existence of thalassaemia major and chronic myeloid leukaemia (CML) is a very rare event. We report a 32-year-old man with thalassaemia major whose progressively increasing leukocytosis and thrombocytosis led to the diagnosis of CML confirmed by the characteristic t(9;22)(q34;q11) chromosomal translocation and the bcr-abl (b3a2) DNA fusion. The patient was treated with hydroxyurea and anagrelide. This combination resulted in the satisfactory control of both the white blood cell and platelet counts, which has continued over the past 14 months with no major side-effects, albeit with no molecular response. The administration of hydroxyurea was also associated with a significant HbF increase.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据